These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32785223)

  • 41. [Law in health].
    Orv Hetil; 2009 Jul; 150(28):1335-6. PubMed ID: 19581163
    [No Abstract]   [Full Text] [Related]  

  • 42. Adaptive licensing and facilitated regulatory pathways: A survey of stakeholder perceptions.
    Liberti L; Stolk P; McAuslane N; Somauroo A; Breckenridge AM; Leufkens HG
    Clin Pharmacol Ther; 2015 Nov; 98(5):477-9. PubMed ID: 25877216
    [No Abstract]   [Full Text] [Related]  

  • 43. Anti-malarial drug quality in Lagos and Accra - a comparison of various quality assessments.
    Bate R; Hess K
    Malar J; 2010 Jun; 9():157. PubMed ID: 20537190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Front line of combating counterfeit medicines, globally and locally].
    Kimura K
    Yakugaku Zasshi; 2014; 134(2):195-6. PubMed ID: 24492222
    [No Abstract]   [Full Text] [Related]  

  • 45. Against the tide: current perspectives in Brazilian drug policy.
    Bastos FI
    Cad Saude Publica; 2013 Feb; 29(2):216-8. PubMed ID: 23459801
    [No Abstract]   [Full Text] [Related]  

  • 46. Regulatory aspects of specific immunotherapy in Europe.
    Kaul S; Englert L; May S; Vieths S
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):594-602. PubMed ID: 20864886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
    Nsimba SE
    East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complementary medicines: When regulation results in revolution.
    Fourie L; Oosthuizen F; Du Toit K
    S Afr Med J; 2017 May; 107(6):483-485. PubMed ID: 28604318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Guidelines and strategy of the International Conference of Harmonization (ICH) and its member states to overcome existing impurity control problems for antibiotics in China.
    Jiang Y; Xia JP; Yang JH; Zhang ZF; Hu CQ; Zhang ZR
    Chin J Nat Med; 2015 Jul; 13(7):498-506. PubMed ID: 26233840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fake artesunate in southeast Asia.
    Newton P; Proux S; Green M; Smithuis F; Rozendaal J; Prakongpan S; Chotivanich K; Mayxay M; Looareesuwan S; Farrar J; Nosten F; White NJ
    Lancet; 2001 Jun; 357(9272):1948-50. PubMed ID: 11425421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Institutional accreditation of Health Services in Italy: the long road to quality.
    Fortino A; Di Stanislao F
    Blood Transfus; 2014 Apr; 12 Suppl 3(Suppl 3):s551-3. PubMed ID: 24922294
    [No Abstract]   [Full Text] [Related]  

  • 52. Counterfeit medications and their negative impacts on health care.
    Fincham JE
    Am J Pharm Educ; 2014 Apr; 78(3):48. PubMed ID: 24761009
    [No Abstract]   [Full Text] [Related]  

  • 53. Regional regulatory harmonisation initiatives: Their potential contribution to the newly established African Medicines Agency.
    Ngum N; Ndomondo-Sigonda M; Walker S; Salek S
    Regul Toxicol Pharmacol; 2023 Dec; 145():105497. PubMed ID: 37778434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Best practices in the African Medicines Regulatory Harmonization initiative: Perspectives of regulators and medicines manufacturers.
    Ndomondo-Sigonda M; Azatyan S; Doerr P; Agaba C; Harper KN
    PLOS Glob Public Health; 2023; 3(4):e0001651. PubMed ID: 37186241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Balancing risks and benefits in pain medicine: wither Vioxx.
    Gallagher RM
    Pain Med; 2004 Dec; 5(4):329-30. PubMed ID: 15563316
    [No Abstract]   [Full Text] [Related]  

  • 56. What is being done to address the new drug epidemic?
    Dekker AH
    J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES21-6. PubMed ID: 17908827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recognizing the value of community involvement by AHC faculty: a case study.
    Steiner BD; Calleson DC; Curtis P; Goldstein AO; Denham A
    Acad Med; 2005 Apr; 80(4):322-6. PubMed ID: 15793013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pill problem: prescription drug abuse is the fastest growing form of substance abuse.
    Hanson K
    State Legis; 2010 Mar; 36(3):22-5. PubMed ID: 20306600
    [No Abstract]   [Full Text] [Related]  

  • 59. Japanese Oriental medicine.
    Hori T
    World Neurosurg; 2010 Jun; 73(6):638. PubMed ID: 20934147
    [No Abstract]   [Full Text] [Related]  

  • 60. The latest buzz on medicinal marijuana: a legal and medical perspective.
    Steinborn JJ; Chinn AK; Carter GT
    Am J Hosp Palliat Care; 2001; 18(5):295, 298. PubMed ID: 11565181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.